This study demonstrated that transient pre-hypertensive treatment (TPT) with angiotensin II type 1 receptor (AT1R) blocker compared with placebo successfully delayed new onset of hypertension in a cohort of pre-hypertensive subjects within 2 years. Here, AGTR1 is linked to Hypertension.